Atea Pharmaceuticals
AVIR
AVIR
125 hedge funds and large institutions have $327M invested in Atea Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 15 closing their positions.
Holders
125
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.16%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
50
Reduced
34
Closed
15
Calls
$13.4M
Puts
$540K
Net Calls
+$12.8M
Net Calls Change
-$208K
Top Buyers
| 1 |
1
BlackRock
New York
|
$44.8M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$43.2M |
| 3 |
ABG
3
Ally Bridge Group
New York
|
$2.05M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$7.9M |
| 5 |
5
First Trust Advisors
Wheaton,
Illinois
|
$1.13M |
